Harvest One Cannabis Inc (CVE:HVT) (OTCQX:HRVOF) has announced the launch of its new LivRelief Extra Strength Transdermal CBD Cream as part of its strategic growth and brand expansion initiatives for 2021.
In a statement, Harvest One CEO Gord Davey said: "Harvest One's LivRelief CBD Cream continues its momentum of being the top-selling SKU in the infused topicals category in Ontario for the 12-month period ended March 2021, as ranked by dollars sold, based on OCS Sales Data.”
“The company is excited to announce the launch of its new LivRelief Extra Strength Transdermal CBD Cream, which will launch on the Medical Cannabis by Shoppers platform in June 2021,” he added.
The Vancouver, British Columbia-based company said that pipeline development and product innovation are key strategic initiatives. The company intends to develop its cannabis-infused topicals to bolster its leadership position in the market by expanding its offerings in Canada and key global markets where it is legal.
The new LivRelief Extra Strength Transdermal CBD Cream contains 750 milligrams of CBD. The firm said it will offer consumers "three times the amount of cannabinoids found in the LivRelief CBD Cream."
“With Harvest One's infused topical portfolio of LivRelief CBD Cream, LivRelief 1:1 Cream formulation, and now LivRelief Extra Strength Transdermal CBD Cream, consumers are afforded more choices,” noted the company.
Contact the author Uttara Choudhury at email@example.com
Follow her on Twitter: @UttaraProactive